Journal of Clinical Oncology, Vol 10, 346-a, Copyright © 1992 by American Society of Clinical Oncology
Granulocyte-Macrophage Colony-Stimulating Factor Mitigates the Neutropenia of Combined Interferon Alfa and Zidovudine Treatment in Acquired Immune Deficiency Syndrome-Associated Kaposi's Sarcoma
David T. Scadden ,
Harriet A. Bering ,
James D. Levine ,
Jocelyn Bresnahan ,
Lydia Evans ,
Carol Epstein , ,
Jerome E. Groopman
Units of measure were incorrect in two reports: In "Granulocyte-Macrophage Colony-Stimulating Factor Mitigates the Neutropenia of Combined Interferon alfa and Zidovudine Treatment in Acquired Immune Deficiency Syndrome-Associated Kaposi's Sarcoma" by Scadden et al (J Clin Oncol 9:802808, 1991), under "Treatment Regimen," the unit of measure for granulocyte-macrophage colony-stimulating factor should have been "µg/m2." In the editorial, "Transfusion-Associated Graft-Versus-Host Disease" by K. Anderson (J Clin Oncol 9:17271730, 1991), the unit of measure for irradiation of blood products should have been "Gy."